{"nctId":"NCT00530946","briefTitle":"A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin","startDateStruct":{"date":"2007-09"},"conditions":["Hypertension","Hypercholesterolemia"],"count":165,"armGroups":[{"label":"CI-1038 2.5mg/5mg","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Amlodipine 2.5mg/Atorvastatin 5mg"]},{"label":"CI-1038 2.5mg/10mg","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Amlodipine 2.5mg/Atorvastatin 10mg"]},{"label":"CI-1038 5mg/5mg","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Amlodipine 5mg/Atorvastatin 5mg"]},{"label":"CI-1038 5mg/10mg","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Amlodipine 5mg/Atorvastatin 10mg"]}],"interventions":[{"name":"Amlodipine 2.5mg/Atorvastatin 5mg","otherNames":[]},{"name":"Amlodipine 2.5mg/Atorvastatin 10mg","otherNames":[]},{"name":"Amlodipine 5mg/Atorvastatin 5mg","otherNames":[]},{"name":"Amlodipine 5mg/Atorvastatin 10mg","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* The out-patient with concurrent hypertension and hyper-LDL-cholesterolemia is a male or female \\>=20 to \\<80 years of age at Visit 1.\n* The SBP at Visit 4 (Week -1) and Visit 5 (Week 0) is continuously SBP \\>=140 mmHg and \\<180 mmHg,\n* LDL-C \\>=140 mg/dL and \\<250 mg/dL at Visit 3 (Week -2) and 4 (Week -1).\n\nExclusion Criteria:\n\n* Subjects who had experienced the following coronary artery disease within the past 3 months.\n* Myocardial infarction\n* Receiving PCI（percutaneous coronary intervention）or CABG (coronary artery bypass grafting)\n* Any clinically meaningful valvular disease\n* Subjects with a history of cerebrovascular diseases such as stroke or transient ischemic attack within the past 3 months.","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"79 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Systolic Blood Pressure","description":"Value at Week 8 minus value at baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.6","spread":"1.65"},{"groupId":"OG001","value":"-15.9","spread":"1.69"},{"groupId":"OG002","value":"-21.8","spread":"1.69"},{"groupId":"OG003","value":"-18.9","spread":"1.71"}]}]}]},{"type":"PRIMARY","title":"Percent Change in Low Density Lipoprotein-Cholesterol","description":"Percent of \"value at Week 8 minus value at baseline\" over value at baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-37.2","spread":"1.49"},{"groupId":"OG001","value":"-42.5","spread":"1.52"},{"groupId":"OG002","value":"-34.3","spread":"1.52"},{"groupId":"OG003","value":"-40.6","spread":"1.54"}]}]}]},{"type":"SECONDARY","title":"Change in Systolic Blood Pressure From Baseline to Each Observation Point","description":"Value at Week 2, Week 4, or Week 8 minus value at baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.8","spread":"9.63"},{"groupId":"OG001","value":"-13.5","spread":"10.18"},{"groupId":"OG002","value":"-19.2","spread":"10.53"},{"groupId":"OG003","value":"-16.0","spread":"9.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.2","spread":"10.26"},{"groupId":"OG001","value":"-14.6","spread":"12.33"},{"groupId":"OG002","value":"-20.2","spread":"11.08"},{"groupId":"OG003","value":"-19.6","spread":"11.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.8","spread":"11.40"},{"groupId":"OG001","value":"-15.3","spread":"11.59"},{"groupId":"OG002","value":"-21.3","spread":"10.07"},{"groupId":"OG003","value":"-18.7","spread":"11.24"}]}]}]},{"type":"SECONDARY","title":"Change in Diastolic Blood Pressure From Baseline to Each Observation Point","description":"Value at Week 2, Week 4, or Week 8 minus value at baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.9","spread":"6.23"},{"groupId":"OG001","value":"-6.0","spread":"6.05"},{"groupId":"OG002","value":"-8.1","spread":"6.24"},{"groupId":"OG003","value":"-8.2","spread":"6.38"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.3","spread":"4.96"},{"groupId":"OG001","value":"-8.2","spread":"7.13"},{"groupId":"OG002","value":"-9.4","spread":"6.19"},{"groupId":"OG003","value":"-9.2","spread":"6.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.7","spread":"6.34"},{"groupId":"OG001","value":"-8.7","spread":"8.06"},{"groupId":"OG002","value":"-12.0","spread":"6.31"},{"groupId":"OG003","value":"-9.9","spread":"6.57"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Low Density Lipoprotein-Cholesterol From Baseline to Each Observation Point","description":"Percent of \"value at Week 2, Week 4, or Week 8 minus value at baseline\" over value at baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-34.8","spread":"9.11"},{"groupId":"OG001","value":"-42.5","spread":"11.00"},{"groupId":"OG002","value":"-32.8","spread":"9.15"},{"groupId":"OG003","value":"-40.2","spread":"13.52"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-37.4","spread":"7.67"},{"groupId":"OG001","value":"-43.8","spread":"9.30"},{"groupId":"OG002","value":"-35.0","spread":"9.19"},{"groupId":"OG003","value":"-41.8","spread":"9.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-37.6","spread":"7.80"},{"groupId":"OG001","value":"-42.9","spread":"10.28"},{"groupId":"OG002","value":"-34.2","spread":"9.22"},{"groupId":"OG003","value":"-40.8","spread":"11.28"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Total Cholesterol From Baseline to Each Observation Point","description":"Percent of \"value at Week 2, Week 4, or Week 8 minus value at baseline\" over value at baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-24.2","spread":"6.86"},{"groupId":"OG001","value":"-30.5","spread":"8.44"},{"groupId":"OG002","value":"-23.0","spread":"7.22"},{"groupId":"OG003","value":"-28.3","spread":"10.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-26.6","spread":"6.36"},{"groupId":"OG001","value":"-31.5","spread":"7.08"},{"groupId":"OG002","value":"-24.7","spread":"7.64"},{"groupId":"OG003","value":"-28.6","spread":"7.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-26.1","spread":"6.01"},{"groupId":"OG001","value":"-30.0","spread":"8.43"},{"groupId":"OG002","value":"-23.4","spread":"7.78"},{"groupId":"OG003","value":"-28.2","spread":"8.73"}]}]}]},{"type":"SECONDARY","title":"Percent Change in High Density Lipoprotein-Cholesterol From Baseline to Each Observation Point","description":"Percent of \"value at Week 2, Week 4, or Week 8 minus value at baseline\" over value at baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.7","spread":"12.11"},{"groupId":"OG001","value":"8.3","spread":"10.70"},{"groupId":"OG002","value":"6.6","spread":"9.12"},{"groupId":"OG003","value":"9.9","spread":"10.32"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.2","spread":"8.16"},{"groupId":"OG001","value":"7.9","spread":"13.03"},{"groupId":"OG002","value":"9.3","spread":"13.24"},{"groupId":"OG003","value":"11.9","spread":"13.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.2","spread":"10.86"},{"groupId":"OG001","value":"7.5","spread":"13.27"},{"groupId":"OG002","value":"9.7","spread":"10.59"},{"groupId":"OG003","value":"10.8","spread":"9.66"}]}]}]},{"type":"SECONDARY","title":"Percent Change in Triglycerides From Baseline to Each Observation Point","description":"Percent of \"value at Week 2, Week 4, or Week 8 minus value at baseline\" over value at baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-15.1","spread":"33.82"},{"groupId":"OG001","value":"-27.4","spread":"22.48"},{"groupId":"OG002","value":"-16.2","spread":"20.00"},{"groupId":"OG003","value":"-23.9","spread":"24.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.2","spread":"25.31"},{"groupId":"OG001","value":"-25.7","spread":"18.15"},{"groupId":"OG002","value":"-15.1","spread":"22.42"},{"groupId":"OG003","value":"-23.2","spread":"28.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.1","spread":"19.72"},{"groupId":"OG001","value":"-21.1","spread":"21.68"},{"groupId":"OG002","value":"-10.8","spread":"31.42"},{"groupId":"OG003","value":"-24.0","spread":"25.15"}]}]}]},{"type":"SECONDARY","title":"Change in Low Density Lipoprotein-Cholesterol/ High Density Lipoprotein-Cholesterol Ratio (LDL-C/HDL-C) From Baseline to Each Observation Point","description":"Value at Week 2, Week 4, or Week 8 minus value at baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.2","spread":"0.58"},{"groupId":"OG001","value":"-1.4","spread":"0.42"},{"groupId":"OG002","value":"-1.1","spread":"0.49"},{"groupId":"OG003","value":"-1.3","spread":"0.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.3","spread":"0.41"},{"groupId":"OG001","value":"-1.4","spread":"0.42"},{"groupId":"OG002","value":"-1.2","spread":"0.56"},{"groupId":"OG003","value":"-1.4","spread":"0.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.2","spread":"0.37"},{"groupId":"OG001","value":"-1.4","spread":"0.44"},{"groupId":"OG002","value":"-1.2","spread":"0.52"},{"groupId":"OG003","value":"-1.4","spread":"0.52"}]}]}]},{"type":"SECONDARY","title":"Change in Total Cholesterol/ High Density Lipoprotein-Cholesterol Ratio (TC/HDL-C) From Baseline to Each Observation Point","description":"Value at Week 2, Week 4, or Week 8 minus value at baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.3","spread":"0.71"},{"groupId":"OG001","value":"-1.6","spread":"0.49"},{"groupId":"OG002","value":"-1.2","spread":"0.61"},{"groupId":"OG003","value":"-1.5","spread":"0.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.4","spread":"0.48"},{"groupId":"OG001","value":"-1.6","spread":"0.49"},{"groupId":"OG002","value":"-1.4","spread":"0.69"},{"groupId":"OG003","value":"-1.6","spread":"0.59"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.3","spread":"0.43"},{"groupId":"OG001","value":"-1.5","spread":"0.51"},{"groupId":"OG002","value":"-1.4","spread":"0.65"},{"groupId":"OG003","value":"-1.5","spread":"0.62"}]}]}]},{"type":"SECONDARY","title":"Change in Apolipoprotein B From Baseline to Each Observation Point","description":"Value at Week 2, Week 4, or Week 8 minus value at baseline","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-36.6","spread":"12.55"},{"groupId":"OG001","value":"-45.8","spread":"12.11"},{"groupId":"OG002","value":"-33.5","spread":"9.86"},{"groupId":"OG003","value":"-44.4","spread":"15.46"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-40.1","spread":"10.94"},{"groupId":"OG001","value":"-47.2","spread":"10.20"},{"groupId":"OG002","value":"-36.6","spread":"11.36"},{"groupId":"OG003","value":"-45.8","spread":"13.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-40.2","spread":"9.65"},{"groupId":"OG001","value":"-46.4","spread":"10.87"},{"groupId":"OG002","value":"-36.6","spread":"12.27"},{"groupId":"OG003","value":"-45.1","spread":"14.39"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":43},"commonTop":["Nasopharyngitis","Pain in Extremity","Headache","Nausea","Seasonal Allergy"]}}}